SERUM INSTITUTE OF INDIA PVT LTD UNIT VI

Company Nature: Factory (Manufacturer)

Enterprise Introduction:

SERUM INSTITUTE OF INDIA PVT LTD UNIT VI is a manufacturing unit of Serum Institute of India (SII), which is globally recognized as the world's largest vaccine manufacturer by dose. Located in Pune, India, SII is a prominent biotechnology and biopharmaceutical company.

This specific unit, like other facilities under Serum Institute of India, is dedicated to the research, development, and large-scale production of a diverse portfolio of vaccines and immunobiologicals. Its primary function is the manufacturing of high-quality, affordable vaccines for various diseases, including but not limited to polio, diphtheria, tetanus, pertussis, Hib, BCG, r-Hepatitis B, measles, mumps, rubella, and more recently, COVID-19 vaccines.

The company plays a crucial role in global public health, supplying vaccines to over 170 countries through various international organizations like UNICEF and PAHO. SERUM INSTITUTE OF INDIA PVT LTD UNIT VI operates as a factory, focusing on advanced manufacturing processes, rigorous quality control, and packaging, all in compliance with strict international regulatory standards.

The Serum Institute of India Pvt Ltd Unit VI manufactures or sells the following products:

Diphtheria Tetanus Pertussis (DTwP and DTaP) vaccines, Measles Mumps Rubella (MMR) vaccines, Measles vaccine, Hepatitis B vaccine, Haemophilus influenzae type b (Hib) vaccine, Pneumococcal Conjugate Vaccine (Pneumosil), Rotavirus vaccine (Rotasiil), Human Papillomavirus (HPV) vaccine (Cervavac), Polio vaccines (Oral Polio Vaccine and Inactivated Polio Vaccine), Meningococcal vaccines, Rabies vaccine, Tetanus Toxoid vaccine, Tetanus Antitoxin, Diphtheria Antitoxin, COVID-19 vaccine (Covishield and Covovax).